Navigation Links
Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials
Date:7/22/2014

Seattle, WA (PRWEB) July 22, 2014

Quorum Review IRB, the industry leader in central IRB services, announces a new service for large clinical trials called Quick Step™. The offering went live on July 1, 2014 and is designed to address the research industry’s need for seamless study start-up with a large volume of researcher sites. The service is available for studies planning 50 or more North American investigator sites, as well as related studies with a combined planned North American site count of 80 or more. Qualifying studies may also enroll international sites after the minimum for North America is met.

The Quick Step™ program bundles efficiency features that only an IRB of Quorum’s expertise and size can offer. Quick Step™ includes a study manager that is assigned before IRB submission; five hours of complimentary regulatory consulting from one of Quorum’s six in-house attorneys; facilitated completion of our Central Study Questionnaire (CSQ); identification of potential sites for enrollment; and assisted site outreach. Additionally, for the purpose of site enrollment, Quorum can migrate certain site data from related studies already under Quorum’s oversight, as well as data from other IRB forms for studies being transferred to Quorum.

The first stage in Quick Step™ is the assignment of a Quorum Study Manager (in advance of study submission) to help clients expedite and customize their submission process for review. The Study Manager also helps clients determine how best to use their five hours of complimentary regulatory consulting—perhaps for protocol/consent discussion or international country selection. Quorum can populate the client’s submission forms and ensure they are taking full advantage of all efficiencies and customizations available to them.

Additional opportunities for customization and efficiency include custom document citations, consent form development, recruitment material processing prior to initial Board review, and complimentary tracking of amendment language into the consent form. Quick Step™ customers have access to research sites from Quorum’s Site Directory and assistance in outreach to potential sites. Quorum’s Outreach Program has been particularly successful at enrolling high numbers of Institutional sites with Quorum as the central IRB. Once Quick Step™ studies are in-house they are prioritized, and turnaround times are measured and reported to the respective client.

Quorum’s CEO Cami Gearhart says of the new service, “Quorum is very excited to offer this new suite of services that will make running these complex and important large clinical studies streamlined and simple.”

For more details on Quorum Review’s new Quick Step™ service, visit http://www.quorumreview.com/quickstep.

About Quorum Review IRB

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 15 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure Web Portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, international ethics review, a specialized Phase I team, and unique processes for minimal risk research.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12021556.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quorum IRB Board Chair to Speak at South Korean Research Summit
2. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
3. Quorum Review IRB and ConsentSolutions Form Strategic Alliance
4. Quorum Review IRB Board Chair Appointed to SACHRP
5. A Critical Review of Analytical Techniques for Improved Living Standards
6. Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board
7. Gordon Hunter’s ‘How Are You, Mother Earth?’ Receives Four Stars from Clarion Review
8. A Review of Cardiovascular Pressure Sensing and Relevant Performance Specifications to Ensure Data Integrity, a New and Upcoming Webinar Hosted by Xtalks
9. Scar Global Clinical Trials Review, H2, 2013
10. Acute Pain Global Clinical Trials Review, H2, 2013
11. Barretts Esophagus Global Clinical Trials Review, H2, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... 2016 , ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., ... over 100 of their own patients with the VetStem Cell Therapy. Each of these ... for their patients. , The veterinarians are Dr Ross Rich former owner of ...
(Date:5/20/2016)... Baltimore, MD (PRWEB) , ... May 20, 2016 , ... ... contaminated with Listeria, as reported by Food Safety News on May 12, 2016(1), demonstrates ... according to Ted Olsen, CEO of Baltimore-based biotech firm, PathSensors, Inc. ...
(Date:5/19/2016)... , May 19, 2016 ... will fully recover given the relentless pressures in pricing ... sure in the investors circle though - numerous opportunities ... Ahead of today,s session, ActiveWallSt.com,s presents four names in ... ), Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ), ...
(Date:5/19/2016)... 19, 2016 - I dati ... durante il 52 ° Congresso ... - Le conclusioni dello studio indicano un ... trattati, di cui il 90% presenta una d urata ... più. Il settantadue per cento dei pazienti ha riscontrato un ...
Breaking Biology Technology:
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):